Literature DB >> 3632918

WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysis.

O Kildahl-Andersen, R Austgulen, J Nissen-Meyer.   

Abstract

WEHI 164 sarcoma cells cultured with monocyte-released cytotoxin (CF) for 4 weeks became resistant to CF-induced cytolysis and were concomitantly rendered resistant to monocyte-induced cytolysis. The resistant cell line (R-WEHI 164) has been stable with respect to resistance to monocyte- and CF-induced lysis for more than 7 months. WEHI 164 and R-WEHI 164 cells adsorbed CF and no significant difference in CF adsorption was observed. The results indicate that CF may be an effector molecule in monocyte-mediated cytolysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3632918     DOI: 10.1007/BF00199381

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  20 in total

1.  Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.

Authors:  M Röllinghoff; N L Warner
Journal:  Proc Soc Exp Biol Med       Date:  1973-12

2.  Principles, problems, and strategies in the use of antigenic mixtures for the enzyme-linked immunosorbent assay.

Authors:  G E Kenny; C L Dunsmoor
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.

Authors:  F Colotta; G Peri; A Villa; A Mantovani
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

4.  YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.

Authors:  S C Wright; B Bonavida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1985-03       Impact factor: 13.506

6.  Production and characterization of cytostatic protein factors released from human monocytes during exposure to lipopolysaccharide and muramyl dipeptide.

Authors:  O Kildahl-Andersen; J Nissen-Meyer
Journal:  Cell Immunol       Date:  1985-07       Impact factor: 4.868

7.  Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin.

Authors:  N Matthews
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

8.  Natural cytotoxicity of human blood monocytes: production of monocyte cytotoxic factors (MCF) during interaction with tumor cells.

Authors:  A Uchida; E Yanagawa
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

9.  Effect of lymphokines on the production of cytostatic protein factors from human monocytes.

Authors:  O Kildahl-Andersen; J Nissen-Meyer
Journal:  Cell Immunol       Date:  1984-12       Impact factor: 4.868

10.  Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility.

Authors:  N Matthews
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

View more
  1 in total

1.  Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.

Authors:  R Austgulen; O Kildahl-Andersen; T Espevik
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.